Published in Hepatitis Weekly, June 5th, 2000
According to R. Schirmbeck and associates in the Department of Medical Microbiology and Immunology at Ulm, hepatitis B virus surface antigen (HBsAg) expression in the liver plays a major role in T1 and T2 immune responses. Hepatitis B virus vaccines prime either of these responses, via the cellular or humoral immunity pathways.
"We tested whether HBsAg-specific immune responses can be established in transgenic mice...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.